Evidence map›Paper›PMID 34833933›Full record

ArticleMolecules (Basel, Switzerland)2021

Prunetin 4'-

Tae-Jin Park, Hyehyun Hong, Min-Seon Kim, Jin-Soo Park, Won-Jae Chi, Seung-Young Kim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Natural Products for Cosmetic Applications.Molecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tae-Jin ParkDepartment of Pharmaceutical Engineering & Biotechnology, Sunmoon University, Asan 31460, Korea.ORCID 0000-0001-6831-7053
Hyehyun HongDepartment of Pharmaceutical Engineering & Biotechnology, Sunmoon University, Asan 31460, Korea.ORCID 0000-0002-0013-3853
Min-Seon KimNatural Product Informatics Research Center, Korea Institute of Science and Technology, Gangneung 25451, Korea.
Jin-Soo ParkNatural Product Informatics Research Center, Korea Institute of Science and Technology, Gangneung 25451, Korea.ORCID 0000-0001-7349-9808
Won-Jae ChiGenetic Resources Assessment Division, National Institute of Biological Resources, Incheon 22689, Korea.
Seung-Young KimDepartment of Pharmaceutical Engineering & Biotechnology, Sunmoon University, Asan 31460, Korea.
Sun Moon University · KRKorea Institute of Science and Technology · KRNational Institute of Biological Resources · KR

Funding

the National Institute of Biological Resources (NIBR), funded by the Ministry of Environment (MOE) of the Republic of Korea NIBR202102109
6 · The paper itself

Abstract

Biorenovation, a microbial enzyme-assisted degradation process of precursor compounds, is an effective approach to unraveling the potential bioactive properties of the derived compounds. In this study, we obtained a new compound, prunetin 4'-

Indexed as

AnimalsAnti-Inflammatory AgentsCell LineCyclooxygenase 2DinoprostoneExtracellular Signal-Regulated MAP KinasesInflammationInterleukin-1betaIsoflavonesJNK Mitogen-Activated Protein KinasesLipopolysaccharidesMacrophagesMiceMitogen-Activated Protein KinasesNF-kappa BNitric OxideAnti-Inflammatory AgentsCyclooxygenase 2DinoprostoneExtracellular Signal-Regulated MAP KinasesInterleukin-1betaIsoflavonesJNK Mitogen-Activated Protein KinasesLipopolysaccharidesMitogen-Activated Protein KinasesNF-kappa BNitric OxideNitric Oxide Synthase Type IIp38 Mitogen-Activated Protein KinasesPhosphatesprunetinTumor Necrosis Factor-alphaanti-inflammatory activitiesbiorenovationMAPK signalingphosphorylationprunetinprunetin 4′-O-phosphate

Identifiers

PMID34833933
PMCPMC8622051
OpenAlexW3211916684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.